LOGIN
Percutaneous Kyphoplasty with Zoledronic Acid for Osteoporotic Vertebral Compression Fractures
September 2023
Percutaneous Kyphoplasty with Zoledronic Acid for Osteoporotic Vertebral Compression Fractures
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Percutaneous kyphoplasty combined with zoledronic acid for the treatment of primary osteoporotic vertebral compression fracture: a prospective, multicenter study.
Arch Orthop Trauma Surg . 2023 Jul;143(7):3699-3706.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
238 patients with primary osteoporotic vertebral compression fractures were randomized to receive either percutaneous kyphoplasty with zoledronic acid (n=119) or percutaneous kyphoplasty alone (n=119). Outcomes of interest included pain on a Visual Analog Scale (VAS), Oswestry Disability Index (ODI), bone mineral density (BMD), procollagen type I N-terminal propeptide (PINP) levels, osteocalcin in...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.